HealthStream (HSTM) PT Raised to $32 at Needham & Company; '1Q Call Highlights Incremental Margin Leverage Coming'
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/23/2026
- Nasdaq ticks up as tech stocks steady; SpaceX worries hit telecoms
- Meta's capital-raising plans expose a major weakness in the AI boom
- Brent crude jumps to highest since April on Houthi-Saudi attacks, UAE oil spill
- BofA flags further downside risk for stocks, yields and dollar
- SpaceX cell-site ambitions lift tower stocks and weigh on carriers
Tweet
Share
E-mailGet Alerts HSTM Hot Sheet
Price: $34.74 +0.43%
Rating Summary:
5 Buy, 10 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 10 | Down: 12 | New: 15
Rating Summary:
5 Buy, 10 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 10 | Down: 12 | New: 15
Join SI Premium – FREE
Needham & Company raised its price target on HealthStream (NASDAQ: HSTM) to $32.00 (from $28.00) while maintaining a Buy rating, following first quarter results and earnings call.
Analyst Scott Berg notes management's earnings call focused on improving sales from the Workforce Solutions segment, while the company remains poised to deliver higher operating margins in 2018, as customers adopt new products driving incremental margin leverage.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- UCB SA (UCB:BB) (UCBJY) PT Raised to EUR340 at TD Cowen
- Graco Inc. (GGG) PT Lowered to $80 at DA Davidson
- Tango Therapeutics Inc. (TNGX) PT Raised to $45 at Wedbush
Create E-mail Alert Related Categories
Analyst Comments, Analyst EPS Change, Analyst EPS View, Analyst PT ChangeRelated Entities
Needham & Company, EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
